InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-10-31 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-09-25 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-09-11 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
No financial data available for NVS.
Company may not file with SEC or CIK is unresolved.
Novartis receives Health Canada approval for Fabhalta® oral treatment for adults with C3G
Alnylam Q1 Earnings Beat Estimates, Amvuttra Sales Drive Y/Y Growth
Here's What Analysts Are Forecasting For Novartis AG (VTX:NOVN) After Its First-Quarter Results
PTC Therapeutics (PTCT) Is Down 5.1% After New Votoplam Huntington’s Data And Novartis Milestone